Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide vs Myo-inositol for Weight Loss in PCOS
NCT03642600Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Feb 2019
- Primary completion
- Feb 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in obesity, polycystic ovary syndrome (PCOS), sponsored by UZ Leuven. Started Feb 2019; status: completed.
02
Drugs
03
Conditions
obesitypolycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT03642600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03642600.